Replies to post #36946 on Ocata Therapeutics Inc fka OCAT

[rocky301]

Dr. Steven Schwartz LA Times Interview/Comments

July 14, 2011

Will the patients regain vision?

The patients’ central vision is already gone. Not rescuable. So the patients we’re enrolling in this trial know they will not be getting their central vision back.

If not to restore vision, what is the goal?

This is a safety trial. It’s not designed to improve vision. It may; and if we see a signal, that would be great news and we’re hoping we will. It’s plausible biologically, but that’s not what we’re looking for.

What results are you hoping to see?

I hope what happens is that we find this is safe and that we can optimize the dosing, and that allows us to move into eyes that are earlier in disease. That could have a real visual upside.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65207248